ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1139

Differential Inflammatory Profile in Experimental Models of Arthritis

Ana C. Ortiz1, Anne Crilly1, Lynette Dunning1, Carmen Huesa1, C. S. Goodyear2, John C. Lockhart1, William R. Ferrell2 and Iain B. McInnes2, 1Institute of Biomedical and Environmental Health Research, University of the West of Scotland, Paisley, United Kingdom, 2Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: chemokines, cytokines, inflammation and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: While osteoarthritis (OA) in humans is characterized by cartilage degradation, osteophyte formation and joint remodeling, inflammation and synovitis are now recognized to contribute to joint pathology. Two experimental models of OA, destabilization of the medial meniscus (DMM) and section of the anterior cruciate ligament (ACL), are commonly used in the study of OA. While these models mimic many of the changes observed in human OA, the role of synovitis and inflammation remains unclear. To address this, inflammation in DMM and ACL models was evaluated.

Methods: All murine procedures were Home Office (UK) approved. OA was induced in 10 week old C57BL/6 male mice by DMM or ACL. SHAM operated and naïve animals were used as controls. Freund’s complete adjuvant (FCA) monoarthritis model was used as a positive control of inflammatory joint disease. Knee joint diameter was assessed prior to induction of arthritis and then every three days thereafter. IVIS technology was used to assess myeloperoxidase activity. After 4 weeks synovium was harvested and used for explant culture. Supernatants were collected after 4 hours and analyzed by Luminex for the presence of inflammatory mediators. In parallel experiments, joints were collected for histological analysis of CD3+ and F4/80+ cells. Data were expressed as mean ± SEM with p<0.05 taken as the criterion of significance, tested using 1 or 2 way ANOVA.

Results: There was no significant change in the knee joint diameter between naïve, SHAM, DMM and ACL at 4 week time point. However, knee joint diameter significantly increased in FCA compared to all other groups (figure 1A) and it was the only model demonstrating elevated myeloperoxidase activity. Also, elevated levels of IL-1β, IFNγ, RANTES and IL-10 were only detected in FCA explant cultures. While histological analysis of the joints demonstrated an absence of CD3+ T cells in both DMM and ACL models, F4/80+ cells were observed within/adjacent to the anterior cruciate ligament in ACL and at the medial collateral ligament in DMM. Importantly, MIP-1β/CCL4 was significantly increased in FCA and OA surgical models compared to naïve (figure 1B). IL-33 was elevated in FCA and ACL models but did not attain significance for DMM (figure 1C).

Conclusion: This study demonstrates that the OA inflammatory milieu within the DMM and ACL synovium differs substantially from the FCA model. Nevertheless, the presence of F4/80+ cells and high levels of MIP-1β/CCL4 within the synovium as well as elevated IL-33 suggests an ongoing low-grade inflammatory process in these OA models.

Acknowledgements: This research was supported by an Arthritis Research UK programme grant (20199). A. Ortiz was supported by University of the West of Scotland PhD studentship. L. Dunning was supported by the Carnegie Trust for the Universities of Scotland.


Disclosure: A. C. Ortiz, None; A. Crilly, None; L. Dunning, None; C. Huesa, None; C. S. Goodyear, None; J. C. Lockhart, None; W. R. Ferrell, None; I. B. McInnes, None.

To cite this abstract in AMA style:

Ortiz AC, Crilly A, Dunning L, Huesa C, Goodyear CS, Lockhart JC, Ferrell WR, McInnes IB. Differential Inflammatory Profile in Experimental Models of Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/differential-inflammatory-profile-in-experimental-models-of-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differential-inflammatory-profile-in-experimental-models-of-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology